EsoGuard™ Esophageal DNA Test
EsoGuard™ is a next generation sequencing (NGS) assay optimized by ResearchDx scientists for the early detection of methylated DNA biomarkers associated with the presence of Barrett’s esophagus. In Barrett’s esophagus the normal squamous cell lining changes to abnormal glandular cells as a result of chronic acid reflux. These cells have the potential to become cancerous unless they are detected and removed by endoscopy or radiofrequency ablation.
The EsoGuard test analyzes cells from the esophagus collected via a quick non-invasive office-based procedure using the EsoCheck device.
For more information about ordering this test, visit luciddx.com
Contact us today to learn more about our extensive array of clinical, esoteric and consulting laboratory services for biopharmaceutical and clinical diagnostics laboratories. Or visit our companion diagnostics company, ResearchDx, to learn how our IVD and biopharma development services can simplify delivery of your FDA-approved companion diagnostics on time.